Wanbury secured EDQM approval for Rivaroxaban API, boosting EU market access.

Wanbury LimitedWANBURY · Filed with the exchange

The company also received USFDA DMF clearances for Paraxetine HCl and Metformin HCl, strengthening its product pipeline and reach for customers.

No comments yet. Be the first.

More from Wanbury Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.